Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Retatrutide (LY3437943) is an investigational triple-agonist drug administered as a once-weekly subcutaneous injection
doi: 10.1016/j.chom.2018.01.006 192 Moreno SantillnDDLamaTMGutierrez GuerreroYTBrownAMDonatPZhaoHet al
Genetic variation in the glucose-dependent insulinotropic peptide receptor (GIPR), and obesity-risk genes like FTO rs9939609 and MC4R rs17782313 may influence how your body responds to appetite-suppressing medications
Stay consistent with your dosing schedule Maintaining your regular dosing schedule is important for continued results
US$ 22.98
US$ 28.55
US$ 21.29
US$ 22.35
US$ 21.63
US$ 20.18
US$ 25.61
